Navigation Links
Rib-X Pharmaceuticals Initiates Phase 2 Trial for RX-3341 In Complicated Skin and Skin Structure Infections
Date:7/15/2008

has yielded several distinctive new antibiotic classes. The Company currently has two programs in human clinical trials, the RX-1741 designer oxazolidinone program as an oral/IV agent to treat serious hospital Gram-positive infections and the RX- 3341 program, a next generation fluoroquinolone, active against a broad spectrum of bacteria, including methicillin-resistant Staphylococcus aureus. Additionally, the Company has multiple drug discovery programs. The first of these programs is focused on design and development of an orally active macrolide for community use for treatment of skin infections, including those caused by MRSA. The second discovery program is directed towards identifying a new chemical class of antibiotics active against multi-drug resistant Gram- negative bacteria.

For more information on the ribosome and the Rib-X mission, please visit the Company website at http://www.rib-x.com.


'/>"/>
SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Rib-X Pharmaceuticals Renews Collaborative Agreement with the Medical Research Council
2. Rib-X Pharmaceuticals to Present at 10th Annual Superbugs & Superdrugs Conference
3. MAP Pharmaceuticals Initiates Phase 3 Clinical Trial in Patients With Migraine
4. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
5. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
6. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
7. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
8. University of Rochester Researcher Named Millennium Pharmaceuticals Career Development Scholar of The Leukemia & Lymphoma Society
9. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
10. Isis Pharmaceuticals Conference Call Notice
11. Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... Dec. 4 Watson Pharmaceuticals, Inc. (NYSE: ... confirmed that its subsidiary, Watson Laboratories, Inc.-Florida, filed an ... and Drug Administration seeking approval to market its 8mg ... owned by Takeda Pharmaceutical Company Limited. Watson,s 8mg ...
(Date:12/4/2009)... disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), ... comorbidities reported to occur more often in people ... versus those without an epilepsy diagnosis, according to ... U.S. ,, Findings from " CNS-Related Comorbidities in ...
(Date:12/3/2009)... 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a ... molecule drugs for the treatment of immune mediated diseases ... webcast and conference call on, Tuesday, December 8, 2009 ... Pacific Time) to discuss clinical data regarding its HDAC ...
Breaking Medicine Technology:Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 2Looking Ahead to AES 2009: New Insights on Comorbidities and Other Considerations for Epilepsy Treatment 3Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2New Nominee for WHO Regional Director for Europe 57339 1New Nominee for WHO Regional Director for Europe 57339 2Haemonetics Signs Comprehensive Agreement with Blood Centers of America 57334 1Haemonetics Signs Comprehensive Agreement with Blood Centers of America 57334 2Shockwave Treatment May Not Be Best for Shoulder Pain 57330 1Shockwave Treatment May Not Be Best for Shoulder Pain 57330 2
(Date:12/5/2009)... Wind Turbines are popping up in the most unusual places, and to ... , ... (PRWEB) December 5, 2009 -- Who would have thought that ... Inc. of Fort Worth, Texas has announced a new line of turbines, ...
(Date:12/4/2009)... employees came together in more than 90 offices nationwide today, ... audit, tax and advisory firm,s support for literacy with charitable ... long history of volunteerism. Instead of holiday parties, our employees ... for some children," said Tim Flynn, Chairman of KPMG. ...
(Date:12/4/2009)... The American Association of Homes and Services for the ... Community Living and Supportive Services (CLASS) provisions remain in the ... for providing support to elders, people with disabilities and their ... health care reform bill that will make it affordable to ...
(Date:12/4/2009)... Advisory and Securities Review Committee of BetterInvesting Magazine ... ) as its February 2010 "Stock to Study" and ... its February 2010 "Undervalued Stock" for investors, informational and educational ... involving its flagship drug Botox and other products as well ...
(Date:12/4/2009)... response to the U.S. Justice Department Drug ... and 19-nor-4,9(10)-androstadienedione as "anabolic steroids", under the ... director and CEO of the Natural Products ... trade association representing retailers and manufacturers of ...
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:KPMG Employees Provide 'Holiday Bear Hugs' and Books in Firmwide Service Day for Children 2Health News:BetterInvesting Magazine Releases February Stock to Study and Undervalued Stock Choicesfor Investors' Informational and Educational Use 2Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2
... pool of middle-ranking health workers offers an overlooked but ... according to a paper published by The Lancet ... workers with more clinical skills than nurses but fewer ... in more than two dozen sub-Saharan countries. ...
... mathematical model of sepsis can help predict deaths, discharges, ... bacterial blood infection.This will help clinicians assess which ... ,Mark S. Roberts and colleagues from the ... study to develop their dynamic microsimulation model. This included ...
... Blood Donor Day, the World Health Organization (WHO) is today ... of safe blood to save the lives of women during ... the beginning of a broader blood safety agenda redefined in ... to safe blood transfusion in support of the Millennium Development ...
... results of a new survey this week at the ... 24/7 culture is having on healthcare professionals job performance ... found that more than one quarter of nurses (27.23%) ... had trouble falling asleep, and 55.38% suffered from a ...
... A new revolutionary weapon for the war against the bulges ... Alli- a fat blocker is the first FDA approved ... prescription. ,The prescription diet drug Xenical has been introduced ... strength on Friday in a reincarnated form dubbed Alli. It ...
... is a new concept catching up fast in the West. ... population carry mobile phones with hundreds of names and numbers ... know which of these numbers belong to the near and dear. ... an accident or had a heart attack and the physicians attending ...
Other Medicine News:Health News:Healthcare Workers Could Be Africa's Secret Weapon in AIDS War 2Health News:WHO Intensifies Work on Safe Blood for Mothers 2Health News:WHO Intensifies Work on Safe Blood for Mothers 3Health News:Insomnia Affects Job Performance A New Survey 2Health News:Alli- a New Weapon for War Against the Bulges 2Health News:Look Out for ICE in Emergency Situations 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: